Has Walter Stanwood, MD received payments from drug or device companies?

Yes. Drug and device makers reported $203,261 in general payments to Walter Stanwood, MD across 69 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Walter Stanwood, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Walter Stanwood, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Walter Stanwood, MD

Orthopaedic Surgery · Plymouth, MANPI 1669445243

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $167,267 of the $203,261 with a category attached, or 82.3%. Shoulder Innovations, Inc. accounts for 90.8% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $93,360, more than ten times the $6,042 reported in 2019. Among orthopaedic surgery clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$203,261in general payments, 2019–2025

Across 69 payments — averaging $2945.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Shoulder Innovations, Inc.$184K
Limacorporate S.p.a.$12K
Lima USA, Inc.$4K
Techmah Medical, LLC$880
Tigon Medical LLC$876
Stryker$299
plus $138 from 3 others

$2,894in ownership & investment interests, 2019–2025

Across 7 payments — averaging $413.46 each. An ownership or investment interest held by the physician or an immediate family member.

Catalyst Orthoscience$3K

What the payments were for

Royalty or licence$167,26782%
Consulting fees$23,20011%
Travel & lodging$11,2216%
Food & beverage$1,5221%
Gifts$240%
Entertainment$270%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Shoulder Innovations, Inc.	38	$184,489
Limacorporate S.p.a.	7	$12,250
Lima USA, Inc.	11	$4,329
Techmah Medical, LLC	2	$880
Tigon Medical LLC	1	$876
Stryker	5	$299
Smith+Nephew	2	$69
Zimmer Biomet	2	$45
Curonix LLC	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

InSet System$183,894
SMR$13,776
SMR Shoulder$1,500
Product Portfolio$1,203
Shoulder Innovations TSA$212
MAKO$106

How this compares

$203,261 in reported general payments places this provider in the 95th percentile of 542 orthopaedic surgery providers in Massachusetts.

See all orthopaedic surgery providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$317,019

Medicare patients

614

Services billed

5,293

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Meloxicam	57	$155
Celecoxib	12	$83
Ibuprofen	14	$72

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Plymouth

Paul TornettaBoston$16.3M
Thomas ThornhillBoston$12M
Stephen MurphyRoxbury Crossing$8M
Andrew FreibergBoston$5.9M
Jon WarnerBoston$5.4M
Wolfgang FitzBoston$3.7M
Brian KwonWaltham$1.9M
Simon ChaoNorth Easton$1.6M
Scott SigmanNorth Chelmsford$1.4M
Michael LangworthyNorth Dartmouth$715K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →